Immunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes.
Galli F, Forin E, Motos A, Molina Saldarriaga FJ, Gabarrus A, Canseco J, Fernandez-Barat L, Barbeta E, Calabretta D, Ceccato A, Bermejo-Martin JF, Ferrer R, Riera J, Penuelas O, Lorente JA, de Gonzalo-Calvo D, Menendez R, Gonzalez J, Palomeque A, Soler-Comas A, Amaya-Villar R, Anon JM, Marino AB, Barbera C, Barberan J, Ortiz AB, Bustamante-Munguira E, Caballero J, Canton-Bulnes ML, Perez CC, Carbonell N, Catalan-Gonzalez M, de Frutos R, Franco N, Galban C, Lago AL, Gumucio-Sanguino VD, Del Carmen de la Torre M, Diaz E, Estella A, Gallego Curto E, Garcia-Garmendia JL, Gomez JM, Huerta A, Jorge Garcia RN, Loza-Vazquez A, Marin-Corral J, Martin Delgado MC, Martinez de la Gandara A, Martinez Varela I, Lopez Messa J, Albaiceta GM, Nieto MT, Novo MA, Penasco Y, Perez-Garcia F, Pozo-Laderas JC, Ricart P, Sagredo V, Sanchez-Miralles A, Sancho Chinesta S, Roche-Campo F, Socias L, Sole-Violan J, Suarez-Sipmann F, Tamayo Lomas L, Trenado J, Ubeda A, Valdivia LJ, Vidal P, Boado MV, Rodriguez A, Ferrer M, Barbe F, Torres A; CIBERESUCICOVID Project investigators (COV20/00110, ISCIII).
Galli F, et al. Among authors: ferrer m.
Pneumonia (Nathan). 2025 Nov 25;17(1):30. doi: 10.1186/s41479-025-00181-z.
Pneumonia (Nathan). 2025.
PMID: 41287034
Free PMC article.